Maximizing results in craniofacial surgery with bioresorbable fixation devices.
The resorbable plating system allows the infant's skull to grow once the system is resorbed, thus not inhibiting the necessary developmental growth seen with the titanium system. Despite marked improvements in long-term outcomes, there are still technical points that can be followed to maximize outcome while reducing and possibly eliminating minor complications such as plate palpability and visibility through the skin as well as skin breakdown over the plate. A retrospective electronic chart review was performed on the pediatric patient population who underwent craniofacial surgery with the use of resorbable fixation devices by the senior author (LG). Fifty-two patients underwent surgical correction for craniosynostosis with resorbable material (Craniosorb, Lactosorb, or Biosorb PDX). This series included patients with brachycephaly (17), anterior plagiocephaly (unilateral coronal synostosis; 16), trigonocephaly (11), multisuture craniosynostosis (7), and Cohen's craniotelencephalic dysplasia (1). The mean age at the time of the operation was 8 months and the mean follow up was 17 months. Eight patients experienced complications related to the resorbable material. Seven of the eight had complete resolution of symptoms after conservative treatment and one patient had complete resolution of the skin infection after plate removal. The purpose of this study was to evaluate the risks and complications with the use of resorbable material to establish guidelines for avoidance of surgical pitfalls that lead to increased risk of morbidity with the use of this material, particularly as it relates to plate visibility under the skin, plate palpability, skin breakdown, and skin infections over the plating system.
Wake Forest University Baptist Medical Center, Plastic and Reconstructive Surgery Department, Winston-Salem, North Carolina, USA.
Claire
C
Sanger
Alfredo
A
Soto
Federico
F
Mussa
Massimiliano
M
Sanzo
Luigi
L
Sardo
Piero Arturo
PA
Donati
Giovanni
G
Di Pietro
Barbara
B
Spacca
Flavio
F
Giordano
Lorenzo
L
Genitori
D020341:Absorbable Implants / Q000009:adverse effects*; D000293:Adolescent; D001672:Biocompatible Materials / Q000009:adverse effects*; D001860:Bone Plates / Q000009:adverse effects; D001863:Bone Screws / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003398:Craniosynostoses / Q000601:surgery*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D016268:Internal Fixators / Q000009:adverse effects*; D007773:Lactates / Q000009:adverse effects*; D008297:Male; D011092:Polyethylene Glycols / Q000009:adverse effects*; D012189:Retrospective Studies
D001672:Biocompatible Materials; D007773:Lactates; C088513:poly(lactic acid-ethylene glycol); D011092:Polyethylene Glycols